Sermorelin Research Guide: Identity, Literature, Analysis and Documentation
Research use only. StarBio products are supplied strictly for in vitro laboratory research by qualified professionals. They are not for human or veterinary use, not for diagnostic or therapeutic use, and have not been evaluated by the FDA. This guide covers identity, documentation and handling only. It is not usage guidance.
Sermorelin is the first 29 residues of human growth-hormone-releasing hormone with a C-terminal amide. That fragment is the shortest piece of the 44-residue hormone that keeps full activity at the receptor in the original binding studies, which is why it became the reference molecule for the whole GHRH-analogue family. Two other compounds in this catalogue, tesamorelin and the CJC-1295 component of the CJC-1295 / Ipamorelin blend, are modifications of this same 29- or 44-residue backbone, so sermorelin is the natural place to start when comparing them as research materials. This page collects the identity data, the areas the published literature covers, the analytical points a 3.4 kDa peptide with a methionine raises, and the documentation position for StarBio’s lot.
Identity
| Name | Sermorelin (GRF(1-29)-NH2; GHRH(1-29) amide; human growth hormone-releasing factor 1-29 amide) |
|---|---|
| Type | Synthetic growth-hormone-releasing hormone analogue, N-terminal fragment |
| CAS number | 86168-78-7 (free peptide); 114466-38-5 (acetate) |
| Molecular weight | 3357.9 g/mol |
| Formula | C149H246N44O42S |
| Sequence | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 |
| Length | 29 amino acids, C-terminal amide |
Note on sequence sources: some databases list a 30-residue sequence ending in an extra glutamine. That is the 1-30 fragment, not sermorelin, and it does not match the 3357.9 g/mol mass. The 29-residue amide above is the one that corresponds to the CAS entry and the stated formula.
Origin and history
The hormone itself was isolated in 1982 from human pancreatic tumour tissue by two groups working independently, Guillemin’s and Vale’s, and characterised as a 44-residue peptide. Structure-activity work over the following two years showed that the N-terminal 29 residues carried the receptor-binding activity, and a 1984 paper in Biochemical and Biophysical Research Communications described “super-active” analogues of the 1-29 amide. The unmodified 1-29 amide, named sermorelin, was later developed as a pharmaceutical and approved in the United States for a diagnostic use and then a paediatric indication; the product was discontinued in 2008 and the manufacturer’s stated reasons were commercial rather than safety-related. The material StarBio supplies is a synthetic research chemical of the same sequence, sold for laboratory use only. It is not the medicine, and nothing on this page describes a use of it.
What the literature covers
The references on file for this compound are mostly about the receptor and its signalling rather than about sermorelin as a product. They are listed here as areas of study, not as results.
- GHRH receptor structure and signalling. Reviews in Vitamins and Hormones (2001 [5] and 2023 [1]), Receptors and Channels (2002) [2] and Reviews in Endocrine and Metabolic Disorders (2025) [4] describe the receptor, a class B G-protein-coupled receptor, its ligand-binding domain and its downstream signalling.
- Receptor expression outside the pituitary. Work in Neural Regeneration Research (2022) [3] on receptor signalling in experimental ocular inflammation models, and a study of receptor expression in alveolar epithelial cells in Experimental Lung Research [6], are examples of the receptor being studied in tissues other than its classical site.
- Analytical and anti-doping chemistry. Methods for detecting GHRH analogues, including the 1-29 amide and its modified relatives, are described in Drug Testing and Analysis (2021) [7]. This is the paper most directly about the molecule as an analyte.
- Structure-activity origins. The 1984 BBRC paper on super-active 1-29 analogues [8] is the historical root of the whole analogue family.
Analytical notes
At 3358 Da sermorelin ionises well by electrospray and shows up as a series of multiply charged ions (3+, 4+, 5+ are typical); identity is confirmed by deconvolution to the 3357.9 average mass. Because tesamorelin and CJC-1295 (no DAC) are longer and carry modifications, mass alone separates all three cleanly: 3357.9 for sermorelin, 3367.9 for CJC-1295 without DAC (four substitutions on the 1-29 backbone; the DAC-bearing form is 3647.3), and 5135.9 for tesamorelin (the 1-44 amide with a hexenoyl group).
The methionine at position 27 is the main degradation site. Oxidation to the sulfoxide gives a +16 Da species that elutes slightly earlier on reverse-phase HPLC; a clean leading edge on the main peak is the practical sign that the lot has not been mishandled. The asparagine at position 8 and the glutamines at 16 and 24 are candidates for deamidation in solution, which is why the solution-stability line below is short. With three arginines and two lysines the peptide is basic and adsorbs to untreated glass and plastic; low-binding labware matters for quantitative work. Sermorelin is normally supplied as an acetate salt, so an HPLC area percent will sit above the peptide content by weight; the distinction is explained in what 99% purity actually means, and how the two measurements are made is in HPLC and mass spectrometry.
Storage and stability
- Lyophilized powder
- Store at -20 °C
- Protect from light
- Avoid repeated freeze-thaw cycles
- In solution: 2 to 8 °C, short term
General handling notes for lyophilized peptides, including why methionine-containing sequences are treated as oxidation-prone, are in storing lyophilized research peptides.
Documentation for StarBio lots
Every StarBio lot is sent to an independent laboratory. At the time this page was written, no third-party report for the current Sermorelin lot had been published; the product page and the COA library will show the report, laboratory and number as soon as it is released. If you have an order, the verify-lot form connects it to the batch record. We would rather state that a report is pending than show a figure that is not on file.
References
- Halmos G, Szabo Z, Juhasz E, Schally AV. Signaling mechanism of growth hormone-releasing hormone receptor. Vitamins and Hormones, 2023. PMID 37717982.
- Gaylinn BD. Growth hormone releasing hormone receptor. Receptors and Channels, 2002. PMID 12529933.
- Cen LP, Ng TK, Chu WK, Pang CP. Growth hormone-releasing hormone receptor signaling in experimental ocular inflammation and neuroprotection. Neural Regeneration Research, 2022. PMID 35662195.
- Halmos G, Szabo Z, Dobos N, Juhasz E, Schally AV. Growth hormone-releasing hormone receptor (GHRH-R) and its signaling. Reviews in Endocrine and Metabolic Disorders, 2025. PMID 39934495.
- DeAlmeida VI, Mayo KE. The growth hormone-releasing hormone receptor. Vitamins and Hormones, 2001. PMID 11358116.
- Alveolar epithelial cell growth hormone releasing hormone receptor. Experimental Lung Research. (Full citation on the product page’s sources list.)
- Memdouh S, Gavrilovic I, Ng K, Cowan D, Abbate V. Advances in the detection of growth hormone releasing hormone synthetic analogs. Drug Testing and Analysis, 2021. PMID 34665524.
- Super-active analogs of growth hormone-releasing factor (1-29)-amide. Biochemical and Biophysical Research Communications, 1984. DOI 10.1016/0006-291x(84)91647-4.
- PubChem compound summary, Sermorelin, CID 16129620. https://pubchem.ncbi.nlm.nih.gov/compound/16129620
Product page: Sermorelin. Related guides: Ipamorelin research guide, how to read a certificate.
For laboratory research use only. Not for human or veterinary use.
Compared with related compounds: Ipamorelin vs Sermorelin, Sermorelin vs CJC-1295 vs Tesamorelin.
Questions about Sermorelin
What is Sermorelin?
Sermorelin is a gHRH analog (GHRH 1-29 amide): 29 residues, molecular weight 3357.9 g/mol, CAS number 86168-78-7. It is supplied for in vitro laboratory research only. This guide covers identity, documentation and handling, not use.
Is Sermorelin the same as GRF(1-29)-NH2 and GHRH(1-29) amide?
Sermorelin is also listed as GRF(1-29)-NH2 and GHRH(1-29) amide. On a certificate or vial label, the CAS number (86168-78-7) and the sequence identify the material regardless of which name is used.
What are the CAS number, formula and molecular weight of Sermorelin?
Sermorelin has CAS number 86168-78-7, molecular formula C149H246N44O42S and molecular weight 3357.9 g/mol. Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2. Identity of each StarBio batch is confirmed by mass spectrometry on the laboratory report.
Is StarBio's Sermorelin independently tested?
StarBio has not published an independent laboratory report for Sermorelin yet. Reports are added to the COA library as batches are tested.
How should Sermorelin be stored?
Lyophilized powder; Store at -20 °C; Protect from light; Avoid repeated freeze-thaw cycles; In solution: 2-8 °C, short term. StarBio ships it as sealed lyophilized powder.
Where can I buy Sermorelin for laboratory research?
StarBio sells Sermorelin as 10 mg at $59.99, shipped tracked from Florida to all 50 US states. StarBio does not ship internationally. Buyers must be qualified researchers or institutions aged 21 or older, buying for in vitro laboratory work.
New reports and guides, by email
A short note when a new laboratory report is published, when a compound returns to stock, and when a new guide goes up. Nothing else. Leave whenever you like.
For laboratory research use only. No dosing or protocol content is ever sent.

